Skip to content
PubMed This is a summary of 36 peer-reviewed journal articles Updated
Endocrinology

Woodhouse-Sakati syndrome: A Patient Guide

At a Glance

Woodhouse-Sakati syndrome is an ultra-rare inherited condition caused by changes in both copies of DCAF17. It can affect hormones, hair, hearing, learning, speech, and movement, so care is personalized, coordinated, and focused on monitoring and symptom support.

How to Use This Guide: Woodhouse-Sakati syndrome varies widely from person to person. The information here provides a broad overview of what is possible, but it is not a personalized treatment plan. Always work with your specialized care team to make medical decisions, and use local emergency services for urgent symptoms.

Woodhouse-Sakati syndrome (WSS) is an ultra-rare genetic condition that affects multiple systems in the body, requiring a thoughtful and coordinated approach to care. At its core, WSS is caused by pathogenic variants in both copies of a gene called DCAF17, which serves as a biological blueprint for important proteins [1][2]. Because it is so infrequent, you may find that many doctors have never seen a case before, making you an essential partner in your or your child’s medical journey.

The impact of WSS is often understood through three main pillars of health. The endocrine pillar involves the body’s hormones, often leading to delayed or absent puberty, as well as an increased risk for insulin-deficient diabetes and thyroid issues [3]. The ectodermal pillar refers to physical traits like the hair, where thinning or loss (alopecia) is a very common early sign [4]. Finally, the neurologic pillar covers a range of symptoms from hearing loss and learning differences to movement challenges like dystonia, which causes involuntary muscle contractions [5].

While every person with WSS has the same underlying genetic cause, the way the condition behaves can vary significantly. Some individuals may experience very mild symptoms for many years, while others may face more rapid changes in their movement or speech [5][6]. Because of this variability, the goal of modern medicine is not a “one-size-fits-all” cure, but rather a personalized and proactive management plan that addresses each symptom as it appears [2].

Living with an ultra-rare diagnosis is a journey of vigilance and advocacy, but it is also a journey supported by practical interventions. Symptom-directed treatments can help many people: tailored hormone replacement can support natural development, specialized rehabilitation therapies can maximize mobility and communication, and regular monitoring ensures that new challenges are caught early [1][7]. By building a dedicated team of specialists, you can focus on preserving function and maximizing the quality of life for the individual with WSS [2][8].

Common questions in this guide

What is Woodhouse-Sakati syndrome, and what causes it?
Woodhouse-Sakati syndrome is an ultra-rare inherited condition caused by disease-causing changes in both copies of the DCAF17 gene. It can affect hormone function, hair, hearing, learning, speech, and movement, and the pattern of symptoms differs from person to person.
What signs and health problems can WSS cause?
Possible signs include delayed or absent puberty, thinning or loss of hair, hearing loss, learning differences, and movement problems such as dystonia. People may also have an increased risk of insulin-deficient diabetes and thyroid problems, and some develop changes in speech.
Does Woodhouse-Sakati syndrome affect everyone in the same way?
No. Some people have mild symptoms for many years, while others experience faster changes in movement or speech. Ongoing assessment helps the care team adjust support as new needs appear.
Which specialists may help manage Woodhouse-Sakati syndrome?
Care may involve an endocrinologist for hormone-related concerns, a neurologist for movement or speech changes, and rehabilitation professionals for mobility and communication. Hearing, learning, and school needs may require additional specialists and coordinated support.
How is Woodhouse-Sakati syndrome managed?
There is no one-size-fits-all treatment plan. Symptom-directed care may include tailored hormone replacement, rehabilitation for mobility and communication, and regular monitoring to identify endocrine, hearing, movement, or other changes early.
What health checks should people with WSS discuss with their care team?
Ask the care team how to monitor endocrine health, including diabetes and thyroid concerns, as well as hearing. Additional assessments may be recommended for movement, speech, learning, and communication needs based on the person's symptoms.
How can families and schools support someone with WSS?
A coordinated care plan can help families share clear information with school staff and relatives about learning, communication, movement, and medical needs. Emotional support, advocacy, and access to specialized services are also important when living with an ultra-rare diagnosis.

Get notified when new evidence is published on Woodhouse-Sakati syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Woodhouse-sakati syndrome with no reportable MRI findings: a case report.

    Irvine RE, Ahmad A

    BMC neurology 2024; (24(1)):359 doi:10.1186/s12883-024-03865-z.

    PMID: 39342163
  2. 2

    Three Siblings With Woodhouse-Sakati Syndrome: A Case Report of A New Saudi Family.

    Alhuzaim ON, Ahmad MM, Sherbeeni SM, et al.

    Cureus 2022; (14(12)):e32225 doi:10.7759/cureus.32225.

    PMID: 36620807
  3. 3

    Expanding on the phenotypic spectrum of Woodhouse-Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review.

    Ali R, Al-Dewik N, Mohammed S, et al.

    American journal of medical genetics. Part A 2022; (188(1)):116-129 doi:10.1002/ajmg.a.62501.

    PMID: 34590781
  4. 4

    Woodhouse-Sakati Syndrome: First report of a Portuguese case.

    Louro P, Durães J, Oliveira D, et al.

    American journal of medical genetics. Part A 2019; (179(11)):2237-2240 doi:10.1002/ajmg.a.61303.

    PMID: 31347785
  5. 5

    Patterns of neurological manifestations in Woodhouse-Sakati Syndrome.

    Bohlega S, Abusrair AH, Al-Ajlan FS, et al.

    Parkinsonism & related disorders 2019; (69()):99-103 doi:10.1016/j.parkreldis.2019.10.007.

    PMID: 31726291
  6. 6

    Phenotypic Variability of c.436delC DCAF17 Gene Mutation in Woodhouse-Sakati Syndrome.

    Almeqdadi M, Kemppainen JL, Pichurin PN, Gavrilova RH

    The American journal of case reports 2018; (19()):347-353 doi:10.12659/ajcr.907395.

    PMID: 29574468
  7. 7

    DCAF17 Mutation in Woodhouse-Sakati Syndrome: A Case Report on a Novel Homozygous Variant.

    Khalili Dehkordi A, Vakili R

    Case reports in pediatrics 2025; (2025()):9913412 doi:10.1155/crpe/9913412.

    PMID: 41058970
  8. 8

    Consensus Recommendations for the Clinical Management of Wolfram syndrome Using a Delphi Method.

    Elliott J, Ahmadi S, Yu-Wai-Man P, et al.

    medRxiv : the preprint server for health sciences 2026; doi:10.64898/2026.07.02.26357130.

    PMID: 42428113

This overview of Woodhouse-Sakati syndrome is for informational purposes and does not replace medical advice. Work with a specialized care team for individualized monitoring, treatment, and urgent concerns.